Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$98.9 - $178.34 $1.01 Million - $1.82 Million
-10,233 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$126.05 - $152.76 $193,360 - $234,333
-1,534 Reduced 13.04%
10,233 $1.56 Million
Q3 2019

Nov 12, 2019

BUY
$125.07 - $143.67 $1.47 Million - $1.69 Million
11,767 New
11,767 $1.56 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $227,204 - $296,691
-2,162 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $242,381 - $290,875
2,162 New
2,162 $291,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.88B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.